跳至主要内容
临床试验/NCT02074306
NCT02074306Unknown不适用

Does UROSHIELD® Influence Bacterial Growth On Endotracheal Tubes

Shaare Zedek Medical Center2 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2016年4月最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
66
试验地点
2
主要终点
Number of days elapse until development of positive sputum culture

研究概览

简要总结

The purpose of this study is to examine the effect of UROSHIELD® (a device which generates low energy ultrasound waves) on development of bacterial colonies on endotracheal tubes, in patient receiving mechanical ventilation, and to determine whether this device lowers the rate of bacterial resistance to antibiotics.

详细描述

Ventilator Associated Pneumonia (VAP) is a common complication in patients treated by mechanical ventilation, supposedly related to development of bacterial colonization on the endotracheal tubes. Therefore many devices were designed to address this issue.

NanovibronixTM Company developed "UROSHIELD®" a device which generates low energy ultrasound wave in the nanometer range, and delivers these waves by an actuator which is connected externally to a urinary catheter. It was shown that using UROSHIELD®, there was reduction in development of bacterial colonies, and lower rate of resistance of bacteria to antibiotics.

Aim of the study:

To examine the effect of UROSHIELD® on development of bacterial colonies on endotracheal tubes, in patient receiving mechanical ventilation, and to determine whether this device lowers the rate of bacterial resistance to antibiotics.

Methods:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Consecutive adult patients, with newly begun mechanical ventilation, will be connected to UROSHIELD® within 48 hours

排除标准

  • Pediatric patients

研究组 & 干预措施

UROSHIELD®

Experimental

Randomly selected patients,(ratio 1:1) with newly begun mechanical ventilation, will be connected to a low energy acustic wave generator UROSHIELD® within 48 hours. Endotracheal secretions will be collected for culture and antibiotic sensitivity every 3 days for 15 consecutive days or until disconnection from the mechanical ventilation.

干预措施: UROSHIELD® (Device)

SHAM UROSHIELD®

Sham Comparator

same as abouve but with Sham device.

干预措施: SHAM UROSHIELD® (Device)

结局指标

主要结局

Number of days elapse until development of positive sputum culture

时间窗: 15-20 days

Sputum for culture will be obtained every 3 days. Number of days till sputum culture will convert from negative to positive one will be calculated and compared for the study and control groups.

次要结局

  • Type of bacteria and antibiotic sensitivity(15-20 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

REUVEN FRIEDMANN

head of geriatric ward

Shaare Zedek Medical Center

研究点 (2)

Loading locations...

相似试验